Current and historical daily PE Ratio for Pharma Mar (
XMAD:PHM
) from 2000 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Pharma Mar stock (XMAD:PHM) PE ratio as of May 22 2024 is 333.52.
More Details
Pharma Mar SA (XMAD:PHM) PE Ratio (TTM) Chart
Pharma Mar SA (XMAD:PHM) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1269
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Pharma Mar PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-22 | 333.5 | 2024-03-15 | 510.0 |
| 2024-05-21 | 333.5 | 2024-03-14 | 521.4 |
| 2024-05-20 | 332.8 | 2024-03-13 | 532.1 |
| 2024-05-17 | 340.0 | 2024-03-12 | 542.1 |
| 2024-05-16 | 335.6 | 2024-03-11 | 546.8 |
| 2024-05-15 | 331.9 | 2024-03-08 | 541.8 |
| 2024-05-14 | 315.4 | 2024-03-07 | 541.8 |
| 2024-05-13 | 315.9 | 2024-03-06 | 532.1 |
| 2024-05-10 | 308.3 | 2024-03-05 | 532.9 |
| 2024-05-09 | 298.3 | 2024-03-04 | 532.9 |
| 2024-05-08 | 294.3 | 2024-03-01 | 547.5 |
| 2024-05-07 | 292.2 | 2024-02-29 | 542.9 |
| 2024-05-06 | 292.6 | 2024-02-28 | 565.0 |
| 2024-05-03 | 288.3 | 2024-02-27 | 600.0 |
| 2024-05-02 | 286.3 | 2024-02-26 | 585.7 |
| 2024-04-30 | 281.9 | 2024-02-23 | 577.9 |
| 2024-04-29 | 276.1 | 2024-02-22 | 588.2 |
| 2024-04-26 | 268.1 | 2024-02-21 | 592.1 |
| 2024-04-25 | 266.9 | 2024-02-20 | 597.1 |
| 2024-04-24 | 263.1 | 2024-02-19 | 600.4 |
| 2024-04-23 | 255.6 | 2024-02-16 | 608.2 |
| 2024-04-22 | 245.6 | 2024-02-15 | 623.2 |
| 2024-04-19 | 243.0 | 2024-02-14 | 624.3 |
| 2024-04-18 | 246.5 | 2024-02-13 | 625.7 |
| 2024-04-17 | 245.6 | 2024-02-12 | 636.4 |
| 2024-04-16 | 245.7 | 2024-02-09 | 637.5 |
| 2024-04-15 | 250.9 | 2024-02-08 | 647.9 |
| 2024-04-12 | 256.7 | 2024-02-07 | 655.0 |
| 2024-04-11 | 256.3 | 2024-02-06 | 668.2 |
| 2024-04-10 | 257.4 | 2024-02-05 | 662.1 |
| 2024-04-09 | 263.5 | 2024-02-02 | 656.4 |
| 2024-04-08 | 259.3 | 2024-02-01 | 670.4 |
| 2024-04-05 | 258.9 | 2024-01-31 | 692.1 |
| 2024-04-04 | 262.4 | 2024-01-30 | 715.7 |
| 2024-04-03 | 260.7 | 2024-01-29 | 733.9 |
| 2024-04-02 | 258.0 | 2024-01-26 | 723.9 |
| 2024-03-28 | 266.1 | 2024-01-25 | 735.7 |
| 2024-03-27 | 510.0 | 2024-01-24 | 748.2 |
| 2024-03-26 | 502.5 | 2024-01-23 | 711.1 |
| 2024-03-25 | 500.7 | 2024-01-22 | 686.1 |
| 2024-03-22 | 508.6 | 2024-01-19 | 682.9 |
| 2024-03-21 | 514.6 | 2024-01-18 | 678.9 |
| 2024-03-20 | 513.2 | 2024-01-17 | 685.0 |
| 2024-03-19 | 516.8 | 2024-01-16 | 703.2 |
| 2024-03-18 | 512.1 | 2024-01-15 | 711.1 |
Pharma Mar SA (XMAD:PHM) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Pharma Mar SA
ISIN : ES0169501022
Compare
Compare
Traded in other countries / regions
PHM.Spain0RC6.UKPHMMF.USAPMRA.GermanyPHM.AustriaPHM1.Mexico IPO Date
2000-09-08Description
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers